Approval · Notice of Compliance 2541 · 2001
ACCURETIC: Notice of Compliance 2541
Issued January 18, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2541
- Date
- January 18, 2001
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Angiotensin converting enzyme inhibitor/diuretic
Products in this notice
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- QUINAPRIL HCL 10 MG per TAB
- QUINAPRIL HCL 20 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB